CALL FOR ABSTRACTS
Abstract submission is now closed
Example Abstracts
Please click the links below for example abstract templates
New Tools and Techniques Template
Scientific Study Template
Case Study Template
Blinded Abstract template and guidance
The GCMAS is pleased to accept abstracts in the areas of:
Abstract submission is OPEN NOW and will close on February 2, 2024 through the Helms-Briscoe abstract web portal.
Click here to submit an abstract.
Guidelines for ALL Abstract Submissions
Abstracts are limited to two (2) pages and must be formatted as follows: The content of each page must be contained within a 160 mm X 225 mm (6.3" x 8.8") area. Text should be formatted as Times New Roman 12-pt font.
Abstract reviews WILL be blinded. Please submit TWO VERSIONS of each abstract, 1) a blinded copy and 2) a publication copy (please refer to abstract template files to see unblinded samples and instructions on how to create a blinded version). The publication copy should include the title of the paper, the author(s), affiliation(s) and email address of the corresponding author. The name of the presenting author should be underlined.
The presenting author listed on the abstract will also be required to:
See further Specific Submission Instructions below for additional information for each category of abstract.
Guidelines for Scientific Studies:
Abstracts describing original research should be comprised of the following sections: Introduction, Clinical Significance, Methods, Results, Discussion, References, Acknowledgements, and Disclosure Statement. One or two figures may be used, but please ensure that the figures are legible when reduced to half size.
Guidelines for New Tools and Techniques:
Abstracts describing methodological advances should be comprised of the following sections: Introduction, Clinical Significance, Methods, Demonstration, Summary, References, Acknowledgements, and Disclosure Statement. One or two figures may be used, but please ensure that the figures are legible when reduced to half size. Abstracts should describe novel methods (i.e. devices or algorithms) that enhance our ability to visualize, measure, or analyze the mechanics, tendons, joints, and/or limb segments. Abstracts from vendors are encouraged, but must not contain advertising.
Guidelines for Clinical Case Studies:
Abstracts describing clinical case studies should be comprised of the following sections: Subject History, Clinical Data, Motion Data, Treatment Decisions and Indications, Outcome (if available) Summary, and Disclosure Statement. One or two figures may be used, but please ensure that the figures are legible when reduced to half size. Abstracts should illustrate the value of motion analysis and/or modeling in the evaluation, understanding, and/or treatment of a movement disorder. Priority will be given to studies that include pre- and post-treatment data.